Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity

PURPOSE: Gastric cancer is one of the most common human epithelial malignancies, and using nanoparticles (NPs) in the diagnosis and treatment of cancer has been extensively studied. The aim of this study was to develop hyaluronic acid (HA) containing lipid NPs coloaded with cisplatin (CDDP) and sora...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Feng, Li, Aimei, Liu, Han, Zhang, Hairong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174904/
https://www.ncbi.nlm.nih.gov/pubmed/30323564
http://dx.doi.org/10.2147/DDDT.S176879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174904/
https://www.ncbi.nlm.nih.gov/pubmed/30323564
http://dx.doi.org/10.2147/DDDT.S176879

Ejemplares similares